Is Remedy Meds Legit? Program Cost and Customer Reviews Examined

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Remedy Meds is a legitimate telehealth provider offering compounded semaglutide and tirzepatide medications under licensed clinician supervision. The company holds a 4.7-star rating on Trustpilot (verified September 4, 2026) and advertises month-to-month billing with no long-term commitment. Its verified microdose plan costs $189/month—$60 more per month than PlexusDx's $129 microdose option. Remedy Meds does not publish pricing publicly; figures appear only after completing an intake questionnaire, and in some cases only after providing contact information. Secondary sources report standard-dose semaglutide at $299/month and tirzepatide at $399/month, though these figures were not confirmed during PlexusDx's intake verification and carry mixed evidence status. Detailed customer complaint themes were not captured in available review data.

At-a-glance comparison: Remedy Meds vs PlexusDx

Verified microdose pricing: $189 vs $129 per month

Remedy Meds' microdose plan costs $189/month on a month-to-month basis, verified during PlexusDx's intake process on July 20, 2026. This figure is all-inclusive: medication, clinician visits, phone support, and shipping. The plan bills every 28 days and carries no long-term commitment.

PlexusDx's Microdose GLP-1 Protocol costs $129/month month-to-month, verified the same day. This includes the online provider visit, prescription, compounded medication, and shipping, with no membership fee.

Over 12 months, Remedy Meds' microdose plan totals $2,268 (our calculation: $189 × 12). PlexusDx totals $1,548 ($129 × 12), a difference of $720 per year, or $60 per month.

Standard-dose pricing: secondary evidence and gated disclosure

Remedy Meds does not publish standard-dose pricing on its public website. Figures appear only after completing an intake questionnaire, and in some cases only after the user provides email or phone contact information.

Secondary sources captured September 4, 2026, report $299/month for compounded semaglutide and $399/month for compounded tirzepatide, each described as a 4-week supply with medication, clinician care, and shipping included. These figures carry mixed evidence status; PlexusDx's intake verification reached a contact gate that did not reveal the final price for semaglutide, and the tirzepatide figure is sourced from a Forbes review. Readers should confirm pricing at checkout.

The company's homepage advertises a "$9.99/day" starting price (checked September 4, 2026), which calculates to approximately $299.70 per month if expressed as a 30-day rate. The exact product associated with this marketing teaser is not itemized on the website.

If the secondary $299 semaglutide figure is accurate, Remedy Meds would cost $3,588 over 12 months (our calculation: $299 × 12). PlexusDx's month-to-month semaglutide injection costs $2,268 annually ($189 × 12), and its 6-month commitment option costs $1,788 annually ($149 × 12)—a difference of $1,320 to $1,800 per year depending on commitment length.

If the secondary $399 tirzepatide figure is accurate, Remedy Meds would cost $4,788 over 12 months ($399 × 12). PlexusDx's month-to-month tirzepatide injection costs $3,468 annually ($289 × 12), and its 6-month option costs $2,988 annually ($249 × 12)—a difference of $1,320 to $1,800 per year.

Because Remedy Meds' standard-dose figures were not confirmed during direct intake verification and the company does not publish a public price ladder, prospective patients should complete the intake process to see the final cost before committing.

Customer reviews: 4.7-star Trustpilot rating

Remedy Meds holds a 4.7-star rating on Trustpilot, verified September 4, 2026. This rating indicates broad customer satisfaction. Detailed negative review themes—such as billing disputes, medication delays, or clinician responsiveness issues—were not captured in the research pass, and no coded excerpts from Reddit or other platforms were available.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).

The absence of captured negative themes for Remedy Meds does not mean complaints do not exist; it means the research window did not surface them. Prospective patients should read recent reviews on Trustpilot and consult multiple platforms before deciding.

Legitimacy indicators

Remedy Meds operates under several structural legitimacy markers:

• Licensed clinician oversight: The program includes unlimited clinician video visits (advertised feature, captured July 20, 2026).
• U.S.-based care team: The company advertises 100% U.S.-based phone support and care coordination.
• Month-to-month billing: No long-term contract is required; patients can cancel anytime.
• Results warranty: Remedy Meds advertises a "Guaranteed or it's free" weight loss warranty, though the specific terms and qualifying conditions were not captured.
• Structured intake process: PlexusDx verified that Remedy Meds operates a multi-step intake questionnaire to assess eligibility before prescribing (July 20, 2026).

These features align with standard telehealth GLP-1 program design. However, the gated pricing model—requiring intake completion and in some cases contact information before revealing cost—reduces transparency compared to providers that publish full price ladders publicly.

Medication disclosure and regulatory status

All Remedy Meds products captured in this review are compounded medications. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Compounded GLP-1 medications are not the same as branded drugs such as Ozempic, Wegovy, Mounjaro, or Zepbound, and their safety and efficacy profiles have not been established through the FDA approval process.

Where Remedy Meds may fit

Remedy Meds may suit patients who:

• Prefer a high-touch care model with advertised unlimited video visits and always-on phone support.
• Value a U.S.-based care team and are willing to pay a premium for it.
• Want a results warranty and month-to-month flexibility with no upfront commitment.
• Are comfortable with gated pricing and do not require cost transparency before starting intake.

Where PlexusDx fits

PlexusDx fits patients who:

• Want full pricing published upfront before intake, with no contact gates or marketing teasers.
• Prefer the lowest available microdose cost ($129/month vs $189/month).
• Value multi-month commitment discounts for standard-dose injectables (e.g., semaglutide at $149/month on a 6-month plan vs $189 month-to-month).
• Want optional genetic-medication matching testing ($99 add-on) with a PharmD medication review included.
• Prefer same-price-at-every-dose simplicity: PlexusDx does not raise the monthly rate when a clinician adjusts the dose.

Methodology and freshness

This comparison uses pricing and program details captured between July 20, 2026, and September 4, 2026. Remedy Meds' $189/month microdose figure was verified during PlexusDx's intake process on July 20, 2026. Standard-dose pricing ($299 semaglutide, $399 tirzepatide) was captured September 4, 2026, from secondary sources and carries mixed evidence status; PlexusDx's intake verification reached a contact gate that did not disclose the final semaglutide price, and the tirzepatide figure is sourced from a Forbes review. Trustpilot ratings for both providers were verified September 4, 2026. The 12-month cost calculations and per-month differences are our calculations. No promotional codes, coupons, or limited-time discounts are included. Readers should confirm current pricing, review ratings, and program terms at checkout, as telehealth offerings change frequently.

Frequently Asked Questions

Is Remedy Meds a legitimate telehealth provider?

Yes. Remedy Meds operates under licensed clinician supervision, holds a 4.7-star Trustpilot rating (verified September 4, 2026), offers month-to-month billing with no long-term commitment, and includes a results warranty. Its program structure aligns with standard telehealth GLP-1 models.

How much does Remedy Meds cost per month?

Remedy Meds' verified microdose plan costs $189/month. Secondary sources report $299/month for standard semaglutide and $399/month for tirzepatide, though these figures carry mixed evidence status and were not confirmed during direct intake verification. Pricing is not published publicly and appears only after completing intake.

Does Remedy Meds publish pricing on its website?

No. Remedy Meds does not publish pricing publicly. Figures appear only after completing an intake questionnaire, and in some cases only after providing email or phone contact information. The homepage advertises a "$9.99/day" starting price, but the exact product this represents is not itemized.

How does Remedy Meds' microdose plan compare to PlexusDx?

Remedy Meds' microdose plan costs $189/month; PlexusDx's costs $129/month. Over 12 months, Remedy totals $2,268 and PlexusDx totals $1,548—a $720 annual difference (our calculations). Both are month-to-month with no membership fee and include medication, clinician oversight, and shipping.

Are Remedy Meds medications FDA-approved?

No. All Remedy Meds products captured in this review are compounded medications, which are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for each patient.

Sources

• PlexusDx commercial comparison intake verification, Remedy Meds microdose plan, accessed July 20, 2026
• PlexusDx pricing archive, semaglutide and tirzepatide injection pricing, accessed July 17–23, 2026
• Remedy Meds homepage marketing copy, "$9.99/day" teaser, checked September 4, 2026
• Secondary dataset: Remedy Meds product pricing (semaglutide $299/month, tirzepatide $399/month), mixed evidence status, checked September 4, 2026
• Trustpilot rating verification: Remedy Meds 4.7 stars, PlexusDx 4.3 stars (79% five-star, 83% four-star or higher), accessed September 9, 2026
• Remedy Meds intake process observation (contact gate), checked September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.